Singapore-Dutch JV Launches Home Kit To Test For Cervical Cancer
This article was originally published in PharmAsia News
Executive Summary
Delphi Bioscience Asia, a Singapore-Netherlands joint venture, has launched a home kit to test for cervical cancer, considered an important development in Asia where there is an aversion to the traditional pap smear.